|
Delayed
Toronto S.E.
09:13:02 05/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 12.09 CAD | +0.67% |
|
-2.93% | +52.65% |
| 07:14pm | Satellos Bioscience Granted Composition of Matter Patent for Forazapadin by USPTO | MT |
| 05:33pm | Satellos Bioscience Receives US Patent for Forazapadin | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SATELLOS BIOSCIENCE INC. | Bio Therapeutic Drugs | +0.67% | -2.93% | +52.65% | +25.94% | -32.83% | 18Cr |  |  |  |
- Stock Market
- Stocks
- MSCL Stock
- Charts Satellos Bioscience Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
